Therapeutic Solutions International, Inc.
TSOI
$0.0001
$0.000.00%
OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 14.48% | 36.62% | 42.57% | 43.11% | 30.60% |
| Total Depreciation and Amortization | 11.04% | 6.97% | -0.98% | 27.33% | 37.67% |
| Total Amortization of Deferred Charges | -23.74% | -39.60% | -37.27% | -35.15% | -33.51% |
| Total Other Non-Cash Items | 351.16% | 52.38% | -19.35% | -89.19% | -85.00% |
| Change in Net Operating Assets | -132.14% | -177.46% | -201.70% | -48.94% | 125.05% |
| Cash from Operations | 60.77% | 23.01% | -3.47% | -1.67% | -53.46% |
| Capital Expenditure | 100.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -150.94% | -103.51% | -104.85% | -- | 198.25% |
| Cash from Investing | -155.52% | -111.65% | -112.87% | -- | 190.15% |
| Total Debt Issued | -41.83% | -16.07% | -31.55% | -42.12% | -42.27% |
| Total Debt Repaid | -12.50% | -4.26% | -10.87% | 27.54% | 41.46% |
| Issuance of Common Stock | -56.16% | -0.49% | 251.80% | 77.64% | 52.22% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -50.62% | -5.67% | 69.05% | 14.27% | -1.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -134.29% | -9.83% | 114.23% | 98.31% | -205.47% |